BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
13.19
-0.11 (-0.83%)
At close: Jan 9, 2026, 4:00 PM EST
13.19
0.00 (0.00%)
After-hours: Jan 9, 2026, 5:32 PM EST
BBOT Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$23.83
Upside
+80.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $24 | Buy | Initiates | $24 | +81.96% | Jan 9, 2026 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +89.54% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +51.63% | Dec 5, 2025 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +89.54% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +66.79% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +89.54% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +104.70% | Sep 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +74.37% | Sep 4, 2025 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +89.54% | Aug 18, 2025 |